Sdi Share Discussion Threads

[fillspectre] 05/11/2021 08:13

I was hoping that behind that headline "SDI fashions opportunity for fresh acquisitions" there may have been more insight into the type of acquisition opportunities being pursued by SDI - but it really just a restatement of the RNS. Fils

[bigbigdave] 05/11/2021 07:06

SDI fashions opportunity for fresh acquisitions.

[alter ego] 04/11/2021 14:14

there's an updated research note at Progressive Research. You need to register.

the note is here

[fillspectre] 04/11/2021 11:47

£50K bought at 203p a good sign. £9.2 million profit currently forecast by board for FY 2022. As another poster put it likely to be conservative. Put us on a P/E of 22. The warchest for acquisitions getting larger. All to the good. Fils.

[slogsweep] 04/11/2021 08:37

managed to nip in for a top up not much stock available looks like a big holder has released 29000 to meet retail demand. I think this has a lot further to go. Sold half my holding in April for a big profit but have been buying them back since then

[rivaldo] 04/11/2021 07:10

Trading update - ahead of expectations once again....

Even only halfway through the year, SDI are able to forecast full year profits will be around 4% higher than current forecasts.

Given SDI's usually cautious notifications, one can expect these forecasts to be raised further as the year progresses - especially as revenues are around 7% higher than forecast. 40% organic revenue growth is exceptionally good.

Plus there's a hint that there's lots of acquisition discussions going on in the background. Interestingly, loan facilities have now been expanded to £30m, suggesting larger acquisitions may be on the cards....

[bigalan3] 04/11/2021 07:07

Looks very promising.

[hastings] 04/11/2021 07:07

Another great update from team SDI, ahead of previously upgraded numbers.

[bigbigdave] 04/11/2021 07:07

04 November 2021

SDI Group plc

("SDI", the "Company", or the "Group")

Trading Update

and

Notice of Results

SDI Group plc, the AIM quoted Group focused on the design and manufacture of scientific and technology products for use in digital imaging and sensing control applications, is pleased to announce an update on trading for the current year ending 30 April 2022.

The Group expects to report very strong sales and profits for the half year ended 31 October 2021 ("H1"), with approximately GBP24.7m of Revenue (H1 2021: GBP14.1m; H1 2020: GBP11.4m). Alongside the valuable contributions from Monmouth Scientific and Uniform Engineering, both acquired in the second half of FY 2021, we expect to report organic revenue growth in excess of 40%.

As previously announced, the Atik Cameras division has benefitted in FY 2021 and in FY 2022 from exceptional orders for cameras to be used in real time PCR DNA amplifiers whose end demand is related to testing for COVID-19. Shipments against these orders have continued through H1 2022 but will be substantially reduced in the second half of the financial year, fully in line with expectations.

Performance in other areas of our business has been strong, and the Board expects full year Revenue to be around GBP45m, ahead of current market expectations (1) . In common with much of the manufacturing industry, the Group is experiencing supply chain challenges, but to date we are managing this well. Accordingly, the Board expects full year Adjusted(2) Profit Before Tax to also be modestly above current market expectations at around GBP9.2m (1) .

While we have not completed any acquisitions to date in the year, there has been no shortage of activity with potential targets.

On 1 November 2021, we renewed and expanded our committed loan facility with HSBC to GBP20m, with a further accordion option of an additional GBP10m (at the discretion of HSBC), which, with our current net cash position and strong cash flow, provides sufficient funding for acquisition opportunities.

The Group expects to publish its interim results for the six months to 31 October 2021 on 7 December 2021.

(1) Analysts from our Broker finnCap Limited and from Progressive Equity Research regularly provide research on the Company, and the Group considers the average of their forecasts to represent market expectations for FY 2022 being, prior to this announcement, Revenue of GBP42.05m and Adjusted(2) Profit Before Tax of GBP8.85m

[rivaldo] 03/11/2021 14:11

News today from Chell:



"03.11.21
Chell Instruments Unveil Brand New Pressure Scanner

World-renowned gas measurement and control experts, Chell Instruments have unveiled their newest development, the nanoCAT-LTM-32, a manifold mount miniature etherCAT pressure scanner.

The nanoCAT-LTM-32 brings together the features of two previous models, the manifold feature of the nanoCAT-LTR-64 and the miniature size of the nanoCAT—LTS-32.

Nick Broadley, Managing Director of Chell Instruments, says “The accumulation of these two products takes their very best features and integrates them into one new pressure scanning device. The manifold option allows our customers to create their own manifold, which then bolts onto the nanoCAT-LTM-32, and the miniature features allows for greater ease and flexibility when testing.”

Chell’s brand new pressure scanner has been developed to solve a problem with pressure testing within the motor sport industry. The miniature size of the nanoCAT-LTS-32 accommodates the small F1 wind tunnel model and the manifold feature allows them to test twice as many channel scanners at once.

The nanoCAT-LTM-32 utilises the latest technology in digital transducers.

etc"

[gdjs100] 30/10/2021 07:52

Yes but it was a small auction print setting the close price. Back down to 185p (mids) Monday.

[fillspectre] 30/10/2021 06:00

Is the 5.5p rise yesterday showing correct? If so it has been a good week. Fils.

[fillspectre] 27/10/2021 13:11

Budget speech - becoming a science super power. R&D tax relief focussed on home. All this sounds good for SDI. Fils.

[fillspectre] 27/10/2021 11:12

Not surprising bigbigdave - given that Danske bank have been accumulating recently at these prices. Fils

[bigbigdave] 27/10/2021 09:50

Bit of interest this morning.

[arregius] 26/10/2021 11:24

Monmouth hiring

[hawaly] 25/10/2021 10:39

Pity SDI can't provide the Consultants, Anaesthetists and Nurses to staff these new facilities.....

🤨🤔🤔

GLA

[rivaldo] 25/10/2021 09:06

In addition to the huge investment in life science infrastructure I outlined in post 1369 above, the Government have just announced £5.9 billion of new funding for the NHS.

This to be used "for physical infrastructure and equipment - not day-to-day spending".

£2.1 billion is to be spent on digital infrastucture, but the remaining £3.8 billion should definitely benefit SDI as it's going towards:

"£1.5bn to be spent on more beds, equipment and new "surgical hubs", each with four to five surgical theatres to tackle waiting times"

and

"£2.3bn - will be used to fund more diagnostic tests"

[arregius] 25/10/2021 08:23

Absolutely agree. No rushes, this is a marathon

[rivaldo] 25/10/2021 07:26

...or maybe simply after making the large (by SDI's standards) acquisition of Monmouth Scientific last December, followed by a further small acquisition in February, SDI wanted to take time to bed in Monmouth - which has been carried out successfully - and are continuing their strategy of waiting for the right acquisitions rather than making the wrong ones.

Time to relax and wait for news from Mike and Ken. I would far rather they took their time in acquiring instead of rushing out and making mistakes.

[arregius] 25/10/2021 07:15

Sector is hot and that is my guess why SDI is taking longer to acquire. Sellers dont wanna sell maybe now that they see increased demand maybe?

[rivaldo] 25/10/2021 06:58

Huge life science expansion is happening right next to SDI's Cambridge offices:



Extracts:

"The world’s biggest warehouse landlord is set to build £450 million of new laboratory space in Cambridge as it seeks to cash in on Britain’s booming life sciences sector."

"Prologis, which is based in San Francisco, has bought out Countryside Properties, its London-listed joint venture partner, to take full control of the second phase of expansion at Cambridge Biomedical Campus."

"Prologis will build an extra 400,000 sq ft of office and laboratory space. The first project will involve a 100,000 sq ft, five-storey space costing £65 million."

"Britain’s life sciences industry employs more than 250,000 people and turns over about £81 billion a year. It has emerged as one of the hottest property sectors, with the pandemic having burnished its credentials further in the eyes of investors."

"Blackstone, the American investment group, is spending £850 million building 800,000 sq ft of office and laboratory space in Cambridge, while Brookfield bought several life sciences sites in the golden triangle for £714 million over the summer.

In addition to its £450 million investment in the life sciences sector, Prologis has committed to building another £1.5 billion of warehouse space in Britain over the next three years. The group, which counts Amazon as a tenant, expects that the new warehouses will support about 14,000 jobs."

[starpukka] 22/10/2021 15:08

Appears to be bouncing off the bottom of it's range.

[hastings] 22/10/2021 14:44

Good spot riv. Also seems to be a lot more upgrading and promoting of the Gallenkamp oven business.